These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14281974)

  • 1. OCULAR CHANGES ASSOCIATED WITH LONG-TERM CHLORPROMAZINE THERAPY.
    DELONG SL; POLEY BJ; MCFARLANE JR
    Arch Ophthalmol; 1965 May; 73():611-7. PubMed ID: 14281974
    [No Abstract]   [Full Text] [Related]  

  • 2. SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY.
    GREINER AC; BERRY K
    Can Med Assoc J; 1964 Mar; 90(11):663-5. PubMed ID: 14127375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SKIN PIGMENTATION, CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE TREATMENT.
    MASSEY LW
    Can Med Assoc J; 1965 Jan; 92(4):186-7. PubMed ID: 14232196
    [No Abstract]   [Full Text] [Related]  

  • 4. A CLINICAL STUDY OF PIGMENTARY CHANGE IN CORNEA AND LENS IN CHRONIC CHLORPROMAZINE THERAPY.
    WETTERHOLM DH; SNOW HL; WINTER FC
    Arch Ophthalmol; 1965 Jul; 74():55-6. PubMed ID: 14303344
    [No Abstract]   [Full Text] [Related]  

  • 5. PIGMENT DEPOSITION IN VISCERA ASSOCIATED WITH PROLONGED CHLORPROMAZINE THERAPY.
    GREINER AC; NICOLSON GA
    Can Med Assoc J; 1964 Sep; 91(12):627-35. PubMed ID: 14201249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LENS AND CORENEA CHANGES DURING PHENOTHIAZINE THERAPY: A PRELIMINARY REPORT.
    BARSA JA; NEWTON JC; SAUNDERS JC
    Am J Psychiatry; 1965 Sep; 122():331-2. PubMed ID: 14327480
    [No Abstract]   [Full Text] [Related]  

  • 7. OCULOCUTANEOUS EFFECTS OF CHLORPROMAZINE.
    MATHALONE MB
    Lancet; 1965 Jul; 2(7403):111-2. PubMed ID: 14330034
    [No Abstract]   [Full Text] [Related]  

  • 8. NEW SIDE EFFECTS IN PROLONGED CHLORPROMAZINE THERAPY.
    GREINER AC; NICOLSON GA
    Can Psychiatr Assoc J; 1965 Apr; 10():109-11. PubMed ID: 14286162
    [No Abstract]   [Full Text] [Related]  

  • 9. 7-HYDROXYCHLORPROMAZINE: POTENTIAL TOXIC DRUG METABOLITE IN PSYCHIATRIC PATIENTS.
    PERRY TL; CULLING CF; BERRY K; HANSEN S
    Science; 1964 Oct; 146(3640):81-3. PubMed ID: 14173037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THERAPY OF CHLORPROMAZINE MELANOSIS: A PRELIMINARY REPORT.
    GREINER AC; NICOLSON GA; BAKER RA
    Can Med Assoc J; 1964 Sep; 91(12):636-8. PubMed ID: 14201250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE INCIDENCE AND MANAGEMENT OF CHLORPROMAZINE--SKIN-EYE SYNDROME.
    TREDICI LM; SCHIELE BC; MCCLANAHAN WS
    Minn Med; 1965 May; 48():569-74. PubMed ID: 14274411
    [No Abstract]   [Full Text] [Related]  

  • 12. ABERRATIONS OF THE EYE AND THEIR EFFECTS ON VISION: 1. SPHERICAL ABERRATION.
    JENKINS TC
    Br J Physiol Opt; 1963; 20():59-91. PubMed ID: 14042743
    [No Abstract]   [Full Text] [Related]  

  • 13. [CONTRIBUTION TO THE PROBLEM OF EMMETROPISATION].
    GERNET H
    Ophthalmologica; 1964; 147():235-43. PubMed ID: 14133403
    [No Abstract]   [Full Text] [Related]  

  • 14. Chlorpromazine and the eye of the dog. V. Attempt to produce lenticular lesions.
    Barron CN; Rubin LF; Steelman RL
    Exp Mol Pathol; 1972 Apr; 16(2):169-71. PubMed ID: 5062561
    [No Abstract]   [Full Text] [Related]  

  • 15. OCULOCUTANEOUS CHANGES AFTER YEARS OF HIGH DOSES OF CHLORPROMAZINE.
    CAIRNS RJ; CAPOORE HS; GREGORY ID
    Lancet; 1965 Jan; 1(7379):239-41. PubMed ID: 14238066
    [No Abstract]   [Full Text] [Related]  

  • 16. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 158 Suppl():469-76. PubMed ID: 4982681
    [No Abstract]   [Full Text] [Related]  

  • 17. COMBINED HISTOPATHOLOGIC AND BIOCHEMICAL STUDIES FOLLOWING LONG TERM CHLORPROMAZINE THERAPY. HUMAN POSTMORTEM MATERIAL.
    ROIZIN L; FORREST I; FORREST F
    Trans Am Neurol Assoc; 1963; 88():258-9. PubMed ID: 14272248
    [No Abstract]   [Full Text] [Related]  

  • 18. LENTICULAR AND CORNEAL OPACITIES DURING PHENOTHIAZINE THERAPY.
    BARSA JA; NEWTON JC; SAUNDERS JC
    JAMA; 1965 Jul; 193():10-2. PubMed ID: 14297702
    [No Abstract]   [Full Text] [Related]  

  • 19. Ocular changes occurring with prolonged high dose chlorpromazine therapy. Results from a collaborative study.
    Prien RF; DeLong SL; Cole JO; Levine J
    Arch Gen Psychiatry; 1970 Nov; 23(5):464-8. PubMed ID: 5478574
    [No Abstract]   [Full Text] [Related]  

  • 20. DERMATOLOGICAL AND OPHTHALMOLOGICAL CHANGES ASSOCIATED WITH PROLONGED CHLORPROMAZINE THERAPY.
    FELDMAN PE; FRIERSON BD
    Am J Psychiatry; 1964 Aug; 121():187-8. PubMed ID: 14194222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.